Approximately 60% to 70% of patients aged 18 to 65 years will achieve a complete remission, but just 30.5% of these patients ...
The FDA has approved the biologics license application (BLA) for the subcutaneous (SC) administration of pembrolizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback